UK Pharmaceutical Agreement with U.S. Set to Impact NHS Spending and Drug Prices
The UK is on the verge of finalizing a significant pharmaceutical agreement with the U.S., which would eliminate import tariffs on pharmaceutical goods entering the U.S. market and result in a rise in NHS spending on medications, as per The Times report. The UK government is reportedly set to reduce the industry sales rebate rate on NHS drug prices and enhance the NHS's cost-effectiveness criteria for drugs, based on information from industry insiders. Additionally, the British government is expected to boost the proportion of the NHS budget allocated to pharmaceuticals.
The authenticity of the report could not be immediately confirmed by Reuters.
The landscape of the stock market is being reshaped by AI computing capabilities. Investing.com's ProPicks AI offers a selection of successful stock portfolios curated by our advanced AI technology. So far this year, two-thirds of global portfolios have outperformed their benchmark indexes, with 88% showing positive returns. Our flagship Tech Titans strategy has surpassed the S&P 500's performance in just 18 months, featuring remarkable gains from companies like Super Micro Computer (+185%) and AppLovin (+157%).
Which stock will be the next to experience a significant surge?